Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

A new discovery at the Montreal Neurological Institute at McGill University may provide insights into MS

14.05.2003


A new discovery by scientists at the Montreal Neurological Institute at McGill University may provide insights into Multiple Sclerosis. In a study published in the May issue of the Journal of Neuroscience (J. Neuroscience 2003 23: 3735-3744), Dr. Tim Kennedy and colleagues have discovered that a protein called netrin-1 directs the normal movement of the cells that become oligodendrocytes in the developing spinal cord. Oligodendrocytes are the cells that provide critical support for the nerve cells – they make myelin, the electrical insulation of the central nervous system. They are also the cells that degenerate and die in Multiple Sclerosis (MS). Although oligodendrocytes play an essential role in the nervous system, many aspects of their basic cell biology are not well understood, which is one of the reasons why MS is such a mystery. This research finding identifies a fundamental mechanism that directs migrating oligodendrocyte precursor cells. This has implications for understanding demyelinating diseases such as MS, where even a small myelin deficit can lead to functional impairment of the nerve cell.

... mehr zu:
»Neuroscience »Sklerose

An estimated 50,000 people have MS, which is most often diagnosed in young adults. Its devastating effects last a lifetime and may include problems in seeing or speaking, difficulty with balance and coordination, and even paralysis. “Dr. Kennedy’s research will contribute to the growing body of knowledge which is developing new therapies for MS," said Dr. William McIlroy, MS Society of Canada national medical advisor.

"In order to treat a disease in the most effective way possible, it is necessary to understand the manner in which proteins function," said Dr. Alan Bernstein, President of the Canadian Institutes of Health Research. "Dr. Kennedy’s discovery is a vital step in understanding the root causes of MS and will play a role in one day developing an entirely new generation of drugs to combat this condition."


It is widely known that netrins are proteins that guide nerve cell axons to their target in the developing nervous system leading them to their target. In the embryo, this can involve axons travelling long distances. “In addition to this long-range function, last year we reported that netrin-1 may have a short-range function associated with the cell surface that contributes to the maintenance of nerve cell-oligodendrocyte interactions in the mature nervous system. This prompted us to study the possibility that netrin-1 might contribute to oligodendrocyte development,” says Dr. Tim Kennedy, MNI researcher and co-discoverer of netrins.

The researchers showed that netrin acts as a repellent cue for migrating oligodendrocytes- directing them to move away from sources of netrin. “This result was very exciting for us because netrins are ancient signposts in developing nervous systems,” says Dr. Kennedy. “They’ve been pointing axons in the right direction for at least 500 million years. Although 500 million years ago very simple animals did exist -like little worms, oligodendrocytes had not yet evolved. Evolution has been suggested to work like someone who tinkers with bits and pieces to make new things, like pasting together bits and pieces of other pictures to make a new image. In the natural history of oligodendrocyte cell biology, netrin is an example of something that was already there doing other things, that got picked up along the way and applied to a new purpose.”

“Understanding the basic biology of oligodendrocytes is very important for MS. If we can understand what stimulates them to function, then perhaps we can develop new targets for therapy,” explained Dr. Jack Antel, a neurologist at the Montreal Neurological Institute specializing in the research and treatment of MS.

This research was supported by the Canadian Institutes of Health Research (CIHR) and the Multiple Sclerosis Society of Canada.


For further information or to interview Dr. Kennedy, please contact:
Sandra McPherson
Montreal Neurological Institute
3801 University Street
Montreal, QC H3A 2B4

Tel: (514) 398-1902
Fax: (514) 398-8072
Email: sandra.mcpherson@mcgill.ca

Sandra McPherson | McGill University
Weitere Informationen:
http://www.jneurosci.org/cgi/content/abstract/23/9/3735
http://www.mni.mcgill.ca
http://www.mni.mcgill.ca/announce/kennedy03_e.htm

Weitere Berichte zu: Neuroscience Sklerose

Weitere Nachrichten aus der Kategorie Medizin Gesundheit:

nachricht Sind Epilepsie-Patienten wetterfühlig?
23.05.2017 | Universitätsklinikum Jena

nachricht Dual-Layer Spektral-CT: Bessere Therapieplanung beim Bauchspeicheldrüsenkrebs
18.05.2017 | Deutsche Röntgengesellschaft e.V.

Alle Nachrichten aus der Kategorie: Medizin Gesundheit >>>

Die aktuellsten Pressemeldungen zum Suchbegriff Innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Lässt sich mit Boten-RNA das Immunsystem gegen Staphylococcus aureus scharf schalten?

Staphylococcus aureus ist aufgrund häufiger Resistenzen gegenüber vielen Antibiotika ein gefürchteter Erreger (MRSA) insbesondere bei Krankenhaus-Infektionen. Forscher des Paul-Ehrlich-Instituts haben immunologische Prozesse identifiziert, die eine erfolgreiche körpereigene, gegen den Erreger gerichtete Abwehr verhindern. Die Forscher konnten zeigen, dass sich durch Übertragung von Protein oder Boten-RNA (mRNA, messenger RNA) des Erregers auf Immunzellen die Immunantwort in Richtung einer aktiven Erregerabwehr verschieben lässt. Dies könnte für die Entwicklung eines wirksamen Impfstoffs bedeutsam sein. Darüber berichtet PLOS Pathogens in seiner Online-Ausgabe vom 25.05.2017.

Staphylococcus aureus (S. aureus) ist ein Bakterium, das bei weit über der Hälfte der Erwachsenen Haut und Schleimhäute besiedelt und dabei normalerweise keine...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: Orientierungslauf im Mikrokosmos

Physiker der Universität Würzburg können auf Knopfdruck einzelne Lichtteilchen erzeugen, die einander ähneln wie ein Ei dem anderen. Zwei neue Studien zeigen nun, welches Potenzial diese Methode hat.

Der Quantencomputer beflügelt seit Jahrzehnten die Phantasie der Wissenschaftler: Er beruht auf grundlegend anderen Phänomenen als ein herkömmlicher Rechner....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Tumult im trägen Elektronen-Dasein

Ein internationales Team von Physikern hat erstmals das Streuverhalten von Elektronen in einem nichtleitenden Material direkt beobachtet. Ihre Erkenntnisse könnten der Strahlungsmedizin zu Gute kommen.

Elektronen in nichtleitenden Materialien könnte man Trägheit nachsagen. In der Regel bleiben sie an ihren Plätzen, tief im Inneren eines solchen Atomverbunds....

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Meeresschutz im Fokus: Das IASS auf der UN-Ozean-Konferenz in New York vom 5.-9. Juni

24.05.2017 | Veranstaltungen

Diabetes Kongress in Hamburg beginnt heute: Rund 6000 Teilnehmer werden erwartet

24.05.2017 | Veranstaltungen

Wissensbuffet: „All you can eat – and learn”

24.05.2017 | Veranstaltungen

 
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

DFG fördert 15 neue Sonderforschungsbereiche (SFB)

26.05.2017 | Förderungen Preise

Lässt sich mit Boten-RNA das Immunsystem gegen Staphylococcus aureus scharf schalten?

26.05.2017 | Biowissenschaften Chemie

Unglaublich formbar: Lesen lernen krempelt Gehirn selbst bei Erwachsenen tiefgreifend um

26.05.2017 | Gesellschaftswissenschaften